(8 December 2020) Stock prices of COVID-19 vaccine developers have remained strong, with some exceptional outliers, as the world gets closer to the release of a vaccine against the virus. Fast becoming household names, Moderna, Novavax, Cansino, and Bharat, among other pharma companies, have demonstrated strong growth compared to December 2019 growing in the range of 260-2,100 percent compared to general S&P growth of 18%.

So, where are we at in the vaccine race? As of December 8, 13 COVID-19 candidate vaccines had reached the final (3rd) clinical phase of development, according to the World Health Organization (WHO). Of those in the final stage, China (5) and the United States (3) have the most in play; the remaining five are under development in Belgium, India, Russia, Canada, and the United Kingdom.

  • Usually, before undergoing human clinical trials, a candidate vaccine must go through two initial phases. COVID-19 is of course different. To expedite the development of a vaccine, governments may authorize companies to skip phases, as did Pfizer and Moderna (USA)Sputnik, and five others that are now in the final phase. Six developers skipped the 2nd phase, and three developers in China and one in India skipped both phases one and two. 
  • The Milken Institute offers additional data beyond what is published regularly by the WHO. Milken tracks information about the regulatory review after the 3rd clinical phase as well as preclinical reviews in addition to cataloging treatments in development.

Coronavirus Data and Insights

Live data and insights on Coronavirus around the world, including detailed statistics for the US, EU, and China — confirmed and recovered cases, deaths, alternative data on economic activities, customer behavior, supply chains, and more.

Related Insights from Knoema

Tourism Industry COVID Risk Scoreboard: Travel & Tourism Held Hostage by Coronavirus

(2 July 2021) Though travel and tourism stocks recovered to a pre-crisis level by the end of 2020, financial statement data shows that the COVID-19 pandemic continues to have a strong negative impact on the revenues of companies in the tourism industry. In Q1 2021, sales of Booking Holdings Inc., Expedia Inc. and TripAdvisor Inc. were down 60-65% compared to the same quarter a year ago. This and other data on the pandemic points to a subdued and protracted recovery for the tourism sector. The shape of that recovery will depend largely on what happens with COVID-19. In this...

Global Markets Moved by China Coronavirus Outbreak

(3 February 2020) As the World Health Organization has elevated the global public health threat level posed by the coronavirus to 'very high' (China) and 'high' (rest of the world), global economic health is also beginning to suffer. The number of people affected by the coronavirus globally may seem relatively small — just over 14,632 deaths and 335,953 people infected — yet without containment, especially to avoid spread to countries with weaker healthcare systems, the human (and economic) toll could rise rapidly into a full global epidemic. As the second-largest economy in the...

Apptopia | COVID-19 Impact on Consumer and Business Mobile App Popularity

(27 March 2020) The force that is 'global social exclusion' is becoming a fatal event for some businesses that rely on in-person labor force and customers, while for others it is a chance for rapid growth and development of new services lines. As the coronavirus infections curve worldwide has shifted over recent weeks to become still steeper, entire companies have begun switching to remote work operations. Many industries, such as air travel, tourism, and retail are undergoing rapid business model adjustments to soften the impact of the COVID-19 pandemic. Below we share another...

Coronavirus and the US Consumer by Prosper Insights & Analytics

Prosper Insights & Analytics has 18 years of experience producing market leading monthly survey-based research of consumers' overall confidence. In its most recent survey, Prosper asked consumers about their concerns with regard to the coronavirus pandemic and the related cancellation of major events. You can explore Prosper's latest findings in depth below, but we'll give the spoiler: 82% of US consumers expressed one form of concern or another and believe that they will somehow experience direct consequences of the pandemic. Moreover, for the first time in six months there is...